He had been coughing for months. Everyone told him it was the pollution. Or the change of season. Or stress at work. He was a non-smoker — so surely it could not be lung cancer.
It was.
This is one of the most dangerous myths about lung cancer — that it only affects smokers. The reality is that According to the World Health Organization, lung cancer is the leading cause of cancer deaths worldwide, accounting for approximately 18% of all cancer deaths., and in India it is rapidly becoming one of the most common cancers in men and increasingly in women. And while smoking remains the single biggest risk factor, a significant and growing number of lung cancer cases in India occur in people who have never smoked a single cigarette in their lives.
Lung cancer is dangerous precisely because it is silent. In its early stages — when it is most treatable — it typically causes no symptoms at all. By the time most people are diagnosed in India, the cancer has already reached an advanced stage.
This guide exists to change that. To give you the knowledge to recognise the early warning signs, understand your risk factors, know what diagnosis and treatment involve, and understand why Bangalore is one of the best places in India — and the world — to receive lung cancer care.
What Is Lung Cancer?
Lung cancer is uncontrolled malignant cell growth in the lung tissues. In a healthy body, cells grow, divide and die in an orderly way. Lung cancer begins when cells in one or both lungs undergo changes in their DNA that cause them to grow out of control, forming a tumour that can invade surrounding tissue and spread to other parts of the body.
The lungs are two spongy organs in your chest that take in oxygen when you inhale and release carbon dioxide when you exhale. They are made up of different types of cells — and lung cancer can begin in any of them, though it most commonly starts in the cells lining the airways.
Lung cancer is the most commonly diagnosed cancer globally and the leading cause of cancer-related deaths worldwide — accounting for approximately 18% of all cancer deaths. In India, it accounts for a significant proportion of cancer cases and deaths, with rates rising steadily, particularly in urban areas like Bangalore where air pollution adds to tobacco-related risks.
Types of Lung Cancer — A Complete Guide
Understanding which type of lung cancer is present is critical because different types behave very differently and require different treatment approaches.
The Two Main Categories
1. Non-Small Cell Lung Cancer (NSCLC) — Most Common Type
NSCLC comprises approximately 85% of all lung cancer cases — making it by far the most common form. NSCLC tends to grow more slowly than small cell lung cancer and is typically diagnosed at a more advanced stage because it often causes no early symptoms. In India, NSCLC accounts for approximately 92% of all lung cancer cases.
NSCLC is further divided into three main subtypes:
Adenocarcinoma — Most Common Subtype (43.8% of cases in India) Adenocarcinoma is the most common type of lung cancer, arising in the cells that produce mucus. It typically develops in the outer regions of the lung and is the most common type found in non-smokers and women. In India, the prevalence of adenocarcinoma has increased by 26.4% over the past decade — a worrying trend linked to air pollution and other environmental factors.
Squamous Cell Carcinoma (26.2% of cases in India) Squamous cell carcinoma originates in the squamous cells lining the bronchial tubes — the main airways of the lungs. It is strongly associated with smoking history and typically develops in the central part of the lung, near the main bronchus. It tends to grow in one place for longer before spreading.
Large Cell Carcinoma (2.1% of cases in India) Large cell carcinoma is a fast-growing type of NSCLC that can develop anywhere in the lung. It tends to grow and spread rapidly, making it harder to treat. It accounts for a smaller proportion of cases but requires aggressive treatment.
Other NSCLC Types Including adenosquamous carcinoma and sarcomatoid carcinoma — rare variants that combine features of multiple cell types.
2. Small Cell Lung Cancer (SCLC) — The Most Aggressive Type
SCLC makes up approximately 15% of all lung cancer cases but is disproportionately deadly because of how rapidly it grows and spreads. It is known for its rapid growth and early tendency to metastasise to other organs — including the brain, liver and bones. In India, SCLC has increased by 5.2% over the past decade.
SCLC is almost exclusively linked to smoking. Approximately 9 out of 10 cases of SCLC in men and 8 out of 10 cases in women who develop it are smokers. It is highly sensitive to chemotherapy and radiation in the short term — but it has a very high recurrence rate.
3. Metastatic Lung Cancer
Metastatic lung cancer refers to cancer that has spread from one lung to the other or to other organs in the body. It can also refer to cancer from another organ that has spread to the lungs — most commonly from the breast, colon, kidney, bladder, or prostate. Treating metastatic lung cancer is more challenging compared to cancer that remains confined to its initial site.
Warning Signs — Symptoms of Lung Cancer
This is perhaps the most critical section of this guide — because lung cancer symptoms are often dismissed, misattributed and ignored until the disease is advanced.
Lung cancer symptoms observed may often vary from one patient to another depending on the size of the tumour, its location in the lung, and whether it has spread.
Early Warning Signs (Often Dismissed)
A Persistent Cough That Changes The most common symptom. Not just any cough — but a cough that is new, that gets progressively worse, that changes in character over time, or that simply does not go away. A cough that has lasted more than 3 weeks without clear cause warrants medical evaluation.
Coughing Up Blood (Haemoptysis) Even a small amount of blood when you cough — sometimes appearing as rust-coloured or blood-streaked sputum — is a serious warning sign that should never be ignored or attributed to a minor throat issue.
Chest Pain Persistent chest pain that worsens with deep breathing, coughing or laughing. Pain that radiates to the shoulder or arm may indicate a tumour pressing on nerves or involving the chest wall.
Shortness of Breath Feeling breathless during activities that previously caused no breathlessness — climbing stairs, walking short distances. This occurs when a tumour blocks an airway or fluid builds up around the lung.
Hoarseness of Voice A significant change in the quality of your voice — a new hoarseness or raspiness — that lasts more than two weeks can indicate a lung tumour pressing on the nerve that controls the voice box.
Other Important Symptoms
- Unexplained and significant weight loss — losing weight without trying
- Extreme, persistent fatigue — exhaustion that does not improve with rest
- Recurring chest infections — pneumonia or bronchitis that keeps coming back or does not fully resolve
- Wheezing — a new wheeze without a history of asthma or allergy
- Swelling in the face or neck — may indicate tumour pressing on the superior vena cava (superior vena cava syndrome)
- Bone pain — particularly in the back or hips — may indicate spread to bone
- Headaches, dizziness, seizures or vision changes — may indicate spread to the brain
- Loss of appetite
- Finger clubbing — an unusual curving of the fingernails, associated with lung conditions
Pancoast Tumour Symptoms
A specific type of lung tumour developing at the very top of the lung can cause a distinct set of symptoms called Pancoast syndrome — including severe shoulder pain, arm pain, weakness of hand muscles and a drooping eyelid (Horner syndrome). These symptoms are often initially misdiagnosed as a shoulder or neck problem.
The most important message: In India, 90% of lung cancer patients are diagnosed at an advanced stage. Most of these patients had symptoms earlier but attributed them to minor issues. Do not dismiss a persistent cough, unexplained weight loss, or new chest symptoms — especially if you have any of the risk factors listed below.
Causes and Risk Factors of Lung Cancer
1. Tobacco Smoking — The Leading Cause
Smoking leads to 85 to 90% of all lung cancer cases globally. The risk increases with the number of cigarettes smoked per day and the number of years of smoking. Even secondhand smoke — exposure to someone else’s smoke — significantly increases the risk of lung cancer in non-smokers. Bidi smoking, which is extremely common in India, carries particularly high cancer risks.
2. Air Pollution — A Major Factor in Indian Cities
In India, outdoor air pollution — from vehicle emissions, industrial pollution and construction dust — is a significant contributor to lung cancer in non-smokers. Indoor air pollution from burning biomass fuels (wood, dung, crop residue) for cooking in poorly ventilated homes is also a major risk factor, particularly for women in rural and semi-urban areas.
3. Radon Gas Exposure
Radon is a naturally occurring radioactive gas that seeps from soil and rock and can accumulate in enclosed spaces. It is the second leading cause of lung cancer globally after smoking. When radon decays, it releases radioactive particles that damage lung tissue.
4. Occupational Chemical Exposure
Workers in certain industries face elevated lung cancer risk from long-term exposure to:
- Asbestos (insulation, shipbuilding, construction)
- Arsenic, chromium, beryllium and nickel
- Diesel exhaust fumes
- Coal dust and silica
5. Previous Lung Disease
- Chronic Obstructive Pulmonary Disease (COPD) — significantly increases lung cancer risk
- Pulmonary fibrosis — scarring of the lung tissue
- Tuberculosis (TB) — particularly important in India, where TB prevalence is high. TB increases long-term lung cancer risk even after successful treatment
6. Family History and Genetics
People with a close family member (parent or sibling) who has had lung cancer have a modestly increased risk, even accounting for shared smoking habits. Certain genetic mutations also increase susceptibility.
7. Previous Cancer Treatment
People who have received radiation therapy to the chest for a previous cancer have an elevated risk of developing lung cancer in the treated area.
8. HIV Infection
People living with HIV have a significantly elevated risk of lung cancer — approximately 2-3 times higher than the general population.
9. Age
Lung cancer risk increases with age. Most cases are diagnosed in people over 50, though it can occur at any age.
How Is Lung Cancer Diagnosed?
Early and accurate diagnosis is the single most important factor in lung cancer outcomes. In India, the vast majority of patients are diagnosed at Stage 3 or 4 — when treatment options are more limited. Improving early diagnosis rates is a national health priority.
Diagnostic Tests and Approximate Costs in Bangalore
| Test | Purpose | Approximate Cost |
|---|---|---|
| Chest X-Ray | First-line screening — identifies suspicious shadows or masses | ₹500 – ₹1,500 |
| Low-Dose CT Scan (LDCT) | Gold standard for lung cancer screening in high-risk individuals — detects tumours before symptoms develop | ₹5,000 – ₹12,000 |
| CT Scan (diagnostic) | Detailed imaging of lung tumour size, location and extent | ₹3,500 – ₹10,000 |
| PET-CT Scan | Full-body scan to detect cancer spread to lymph nodes and other organs | ₹15,000 – ₹28,000 |
| MRI Scan | Used when brain metastasis is suspected | ₹5,000 – ₹15,000 |
| Bronchoscopy | Camera passed through the airway to visualise and biopsy tumours near the airways | ₹8,000 – ₹20,000 |
| CT-Guided Needle Biopsy | Needle biopsy of peripheral lung tumours using CT guidance | ₹15,000 – ₹30,000 |
| Sputum Cytology | Microscopic examination of coughed-up mucus for cancer cells | ₹1,000 – ₹3,000 |
| Thoracentesis | Removal and testing of fluid around the lung | ₹5,000 – ₹15,000 |
| Mediastinoscopy | Surgical procedure to examine and biopsy lymph nodes in the chest | ₹20,000 – ₹50,000 |
| Molecular/Genetic Testing | Identifies specific gene mutations (EGFR, ALK, ROS1, PD-L1) that guide targeted therapy | ₹20,000 – ₹60,000 |
| Pulmonary Function Tests | Assesses lung function before surgery | ₹2,000 – ₹5,000 |
Why Molecular Testing Is Critical in Lung Cancer
This deserves special mention. Unlike most cancers, lung cancer — particularly adenocarcinoma — is now understood to have specific genetic driver mutations that can be targeted with precision medicines. In India, EGFR mutations are found in approximately 30-40% of non-squamous NSCLC cases — a higher rate than in Western populations.
If you or a family member is diagnosed with NSCLC, insist on molecular testing before committing to a treatment plan. Testing for EGFR, ALK, ROS1, BRAF, MET, RET and PD-L1 can completely change the treatment approach — from standard chemotherapy to highly effective oral targeted therapy that may be better tolerated and more effective.
Stages of Lung Cancer
NSCLC Staging (Stage 1 to Stage 4)
| Stage | Description | Treatment Outlook |
|---|---|---|
| Stage 1 | Cancer confined to one lung, no spread to lymph nodes | Surgery possible — 5-year survival up to 92% |
| Stage 2 | Cancer in the lung and nearby lymph nodes | Surgery + adjuvant therapy — 5-year survival up to 60% |
| Stage 3A | Cancer spread to lymph nodes in the middle of the chest | Combination treatment — surgery possible in some |
| Stage 3B | Cancer spread more widely in the chest — surgery usually not possible | Chemoradiation — 5-year survival 10-35% |
| Stage 4 | Cancer spread to the other lung or distant organs | Systemic treatment — 5-year survival 10% |
SCLC Staging (Two-Stage System)
| Stage | Description |
|---|---|
| Limited Stage | Cancer found only on one side of the chest — treatable with chemo + radiation |
| Extensive Stage | Cancer spread widely within the chest or to other organs — palliative and systemic treatment |
Treatment Options for Lung Cancer in Bangalore
Treatment for lung cancer is always planned by a multidisciplinary team (MDT) — including a thoracic surgeon, medical oncologist, radiation oncologist, pulmonologist, pathologist and radiologist. The plan depends on the cancer type, stage, genetic profile and the patient’s overall health and fitness.
1. Surgery — For Early-Stage NSCLC
Surgery offers the best chance of cure for early-stage NSCLC. It is generally not used for SCLC or Stage 4 NSCLC.
Types of lung cancer surgery:
- Lobectomy — removal of one entire lobe of the lung. The most common surgical approach for lung cancer. The remaining lobes compensate for the removed lobe over time.
- Pneumonectomy — removal of an entire lung. Used when the tumour involves the central airways or has spread throughout one lung.
- Segmentectomy or Wedge Resection — removal of a segment or wedge of the lung. Used for smaller tumours or in patients who cannot tolerate lobectomy.
- Video-Assisted Thoracoscopic Surgery (VATS) — minimally invasive lung surgery performed through small incisions using a camera and instruments. Results in significantly faster recovery, less pain and shorter hospital stay compared to open surgery.
- Robotic-Assisted Thoracic Surgery — the most advanced approach, available at select centres in Bangalore including Apollo and HCG, offering even greater precision and faster recovery.
2. Radiation Therapy
Radiation therapy uses high-energy X-rays or particles to destroy cancer cells. It is used in multiple ways in lung cancer:
- After surgery (adjuvant radiotherapy) to destroy remaining cancer cells
- As the primary treatment when surgery is not possible
- Combined with chemotherapy (chemoradiation) for Stage 3 NSCLC
- As palliative treatment to relieve symptoms in Stage 4 disease
- For treatment of brain metastases
Advanced radiation techniques available in Bangalore:
- Stereotactic Body Radiation Therapy (SBRT) — extremely precise high-dose radiation delivered in a few sessions, used for early-stage inoperable tumours
- Intensity Modulated Radiation Therapy (IMRT) — shapes the radiation beam to the tumour
- CyberKnife Radiosurgery — robotic, frameless radiosurgery
- TomoTherapy — helical delivery minimising damage to healthy lung tissue
- Proton Therapy — available at select centres, minimises radiation to healthy tissue
3. Chemotherapy
Chemotherapy uses drugs to kill cancer cells throughout the body. In lung cancer it is used as:
- Neoadjuvant chemotherapy — before surgery to shrink the tumour
- Adjuvant chemotherapy — after surgery to reduce recurrence risk
- First-line treatment — for advanced NSCLC without targetable mutations, often combined with immunotherapy
- Primary treatment — for SCLC, usually combined with radiation
- Palliative chemotherapy — to control symptoms and extend life in Stage 4 disease
Common chemotherapy drugs used include Cisplatin, Carboplatin, Paclitaxel, Docetaxel, Gemcitabine, Pemetrexed and Etoposide (for SCLC).
4. Targeted Therapy — A Game Changer for NSCLC
Targeted therapy is one of the most significant advances in lung cancer treatment. These drugs target specific genetic mutations or proteins in the cancer cells — killing cancer cells while largely sparing healthy tissue.
Common targeted therapies used in India:
| Mutation | Targeted Drug | Administration |
|---|---|---|
| EGFR mutation | Gefitinib, Erlotinib, Afatinib, Osimertinib | Oral daily tablet |
| ALK rearrangement | Crizotinib, Alectinib, Brigatinib | Oral daily tablet |
| ROS1 rearrangement | Crizotinib, Entrectinib | Oral daily tablet |
| BRAF V600E | Dabrafenib + Trametinib | Oral tablets |
| MET exon 14 | Capmatinib, Tepotinib | Oral tablet |
For Indian patients with NSCLC, EGFR-targeted therapy (particularly Osimertinib/Tagrisso) has transformed outcomes — many patients achieve years of disease control with an oral tablet instead of IV chemotherapy.
5. Immunotherapy — Harnessing the Immune System
Immunotherapy uses the body’s own immune system to recognise and destroy cancer cells. It has revolutionised lung cancer treatment in the past decade.
Checkpoint inhibitors — particularly drugs targeting PD-1/PD-L1 pathways — are now standard treatment for many patients with advanced NSCLC. These include:
- Pembrolizumab (Keytruda)
- Nivolumab (Opdivo)
- Atezolizumab (Tecentriq)
- Durvalumab (Imfinzi)
PD-L1 testing on the tumour biopsy determines how likely immunotherapy is to be effective. Patients with high PD-L1 expression often respond very well.
Immunotherapy is also being combined with chemotherapy in first-line treatment of advanced NSCLC, significantly improving outcomes compared to chemotherapy alone.
6. Anti-Angiogenic Therapy
Drugs like Bevacizumab (Avastin) work by cutting off the blood supply to the tumour — starving it of the nutrients it needs to grow. It is used in combination with chemotherapy for certain subtypes of advanced NSCLC.
7. Palliative Care
For patients with advanced lung cancer where cure is not possible, palliative care focuses on relieving symptoms — pain, breathlessness, fatigue — and improving quality of life. Modern palliative care is not “giving up” — it is active, expert care that helps patients live as well as possible for as long as possible.
Lung Cancer Treatment Cost in Bangalore — 2026
Surgery Costs
| Procedure | Estimated Cost in Bangalore |
|---|---|
| Lobectomy (VATS — minimally invasive) | ₹3,50,000 – ₹7,00,000 |
| Lobectomy (open surgery) | ₹2,50,000 – ₹5,00,000 |
| Pneumonectomy | ₹4,00,000 – ₹8,00,000 |
| Robotic thoracic surgery | ₹5,00,000 – ₹10,00,000 |
| Wedge resection / Segmentectomy | ₹2,00,000 – ₹4,50,000 |
Radiation Therapy Costs
| Type | Estimated Cost |
|---|---|
| Conventional radiotherapy (full course) | ₹1,00,000 – ₹2,50,000 |
| SBRT / SABR (stereotactic body) | ₹2,50,000 – ₹5,00,000 |
| CyberKnife radiosurgery | ₹3,00,000 – ₹6,00,000 |
Chemotherapy Costs
| Type | Estimated Cost |
|---|---|
| Per chemotherapy cycle | ₹25,000 – ₹80,000 |
| Full course (4-6 cycles) | ₹1,50,000 – ₹6,00,000 |
Targeted Therapy & Immunotherapy
| Treatment | Estimated Monthly Cost |
|---|---|
| EGFR inhibitors (Gefitinib, Erlotinib) | ₹15,000 – ₹50,000/month |
| Osimertinib (Tagrisso) — premium | ₹1,50,000 – ₹2,50,000/month |
| Immunotherapy (Pembrolizumab etc.) | ₹2,00,000 – ₹5,00,000/cycle |
Overall Treatment Package Estimate
| Treatment Approach | Estimated Total Cost |
|---|---|
| Surgery alone (early stage) | ₹3,00,000 – ₹8,00,000 |
| Surgery + adjuvant chemotherapy | ₹5,00,000 – ₹12,00,000 |
| Chemotherapy + Immunotherapy (advanced) | ₹6,00,000 – ₹20,00,000/year |
| Targeted therapy (oral, ongoing) | ₹2,00,000 – ₹30,00,000/year |
India vs World — Cost Comparison
| Country | Lung Cancer Treatment Cost |
|---|---|
| United States | USD 1,00,000 – USD 5,00,000 (₹85 lakh – ₹4 crore) |
| United Kingdom | GBP 50,000 – GBP 2,00,000 (₹55 lakh – ₹2.2 crore) |
| Singapore | USD 50,000 – USD 1,50,000 (₹42 lakh – ₹1.25 crore) |
| Bangalore, India | ₹3,00,000 – ₹20,00,000 |
Bangalore offers savings of 70-90% compared to Western countries — with outcomes in top centres that match international standards.
Survival Rates — Understanding the Numbers
The survival statistics for lung cancer in India are sobering — but they reinforce why early detection matters so much.
| Stage at Diagnosis | 5-Year Survival Rate (NSCLC) |
|---|---|
| Stage 1 (localised) | Up to 92% |
| Stage 2 | Up to 60% |
| Stage 3A | 25 – 35% |
| Stage 3B | 10 – 25% |
| Stage 4 (metastatic) | 5 – 15% |
The critical India-specific statistic: Only 3.5% to 7.2% of lung cancer patients in India are diagnosed at an early stage. The majority — approximately 90% — are diagnosed at an advanced stage. This single fact explains why lung cancer kills more people than any other cancer.
The 5-year survival rate for lung cancer in India overall is approximately 9.6% — compared to 15-19% in the United States and less than 20% in Europe. This gap is almost entirely explained by late diagnosis, not by the quality of treatment.
If lung cancer is caught at Stage 1 and surgically removed, the 5-year survival rate can be as high as 92%. This is why awareness of symptoms and access to early diagnosis are so critical.
Lung Cancer Screening — Who Should Get Screened?
Low-dose CT (LDCT) screening can detect lung cancer at Stage 1 — before any symptoms appear — significantly improving survival rates.
Screening is recommended for:
- Current smokers aged 50-80 who have smoked for 20+ pack-years (1 pack per day for 20 years, or 2 packs per day for 10 years)
- Former smokers who quit within the past 15 years in the above age and smoking history group
- People with other significant risk factors (occupational exposure, family history, previous lung disease) — discuss with your doctor
Doctor Visit Bangalore can help you identify the right screening centre in Bangalore and arrange a low-dose CT screening.
Best Hospitals for Lung Cancer Treatment in Bangalore
| Hospital | Key Strength |
|---|---|
| HCG Cancer Centre, Bangalore | India’s largest dedicated cancer hospital, thoracic oncology, CyberKnife, robotic surgery, molecular diagnostics |
| Apollo Hospitals, Bannerghatta Road | TrueBeam Edge, robotic thoracic surgery, comprehensive lung cancer multidisciplinary team |
| Manipal Hospital, Old Airport Road | Advanced thoracic surgery, Gamma Knife, molecular testing |
| Fortis Hospital, Bannerghatta Road | Experienced thoracic surgery and oncology team |
| Narayana Health — Mazumdar Shaw | Affordable high-volume treatment, advanced radiation oncology |
| Sri Shankara Cancer Hospital | Dedicated cancer centre with thoracic oncology |
| Cytecare Hospitals, Yelahanka | Specialised cancer hospital with advanced technology |
How Doctor Visit Bangalore Can Help You
A lung cancer diagnosis — yours or a loved one’s — changes everything in an instant. The fear, the confusion, the urgency, the questions about where to go and who to trust are overwhelming.
Doctor Visit Bangalore is here to help you navigate this journey with clarity and confidence.
We help you:
✅ Find the most experienced thoracic oncologists and lung cancer specialists in Bangalore
✅ Arrange molecular testing to determine your tumour’s genetic profile before treatment
✅ Get a second medical opinion before committing to a treatment plan
✅ Compare hospitals, technologies and costs transparently
✅ Book confirmed appointments quickly — no long waiting times
✅ Full support for international patients — visa assistance, airport pickup, accommodation coordination ✅ 24/7 WhatsApp assistance throughout your treatment journey
📞 Call / WhatsApp: +91 78920 28951 🌐 www.doctorvisitbangalore.com
Frequently Asked Questions
Q: Can non-smokers get lung cancer? Yes — and this is critically important. While smoking is the leading risk factor, a significant proportion of lung cancers — particularly adenocarcinoma — occur in people who have never smoked. In India, air pollution, indoor pollution from biomass burning, radon exposure, and genetic factors all contribute to lung cancer in non-smokers. Never dismiss persistent respiratory symptoms simply because you do not smoke.
Q: What is the first sign of lung cancer? The most common early symptom is a persistent new cough — or a change in a chronic cough — that does not resolve within 3 weeks. However, lung cancer can cause no symptoms at all in its early stages, which is why screening is important for high-risk individuals.
Q: Is lung cancer always caused by smoking? No. While smoking causes 85-90% of cases, the remaining 10-15% occur in non-smokers. In India, where air pollution levels are severe, a notable proportion of non-smoking lung cancer patients — particularly women — develop the disease due to environmental factors.
Q: What is targeted therapy and is it available in Bangalore? Targeted therapy uses drugs that attack specific genetic mutations in cancer cells. In India, EGFR mutations are found in 30-40% of NSCLC cases — making targeted therapy a highly relevant option. Yes, all major targeted therapy drugs are available at leading cancer centres in Bangalore.
Q: How long does lung cancer treatment take? It depends on the type and stage. Early-stage surgery takes 2-4 hours and recovery takes 4-6 weeks. Chemotherapy cycles are given every 3 weeks, typically for 4-6 cycles over 3-4 months. Targeted therapy and immunotherapy are ongoing — taken for months to years. The full treatment journey varies from a few months to ongoing management.
Q: Can lung cancer be cured? Early-stage NSCLC (Stage 1 and 2) that is completely removed surgically can be cured — with 5-year survival rates of 60-92%. Advanced stage lung cancer is more difficult to cure, but modern targeted therapies and immunotherapies have transformed Stage 4 NSCLC from a rapidly fatal condition to one that can sometimes be managed for years.
Q: What is EGFR mutation and why does it matter? EGFR is a genetic mutation found in the cancer cells of approximately 30-40% of Indian NSCLC patients. If your tumour has an EGFR mutation, targeted therapy with drugs like Osimertinib is significantly more effective than standard chemotherapy. This is why molecular testing before treatment is essential.
Q: How do I find the right lung cancer specialist in Bangalore? Doctor Visit Bangalore can help you identify the most experienced thoracic oncologist and pulmonologist in Bangalore for your specific type and stage of lung cancer, compare hospitals, arrange molecular testing, get a second opinion and book confirmed appointments.
Final Thoughts — The Cough You Should Not Ignore
In India, 9 out of 10 lung cancer patients are diagnosed too late. Not because the cancer did not give warning — but because the warnings were dismissed, misattributed or ignored.
A cough that persists. Unexplained weight loss. Breathlessness that is getting worse. Blood when you cough. These are not trivial symptoms to be dismissed with cough syrup. These are messages your body is sending — and they deserve to be heard.
If you or someone you love has any of the symptoms described in this guide — especially if they are a smoker, have significant exposure to air pollution, or have a family history of lung cancer — see a doctor and ask for a chest CT scan. It could save your life.
Doctor Visit Bangalore is here to help you take that first step.
📞 Call / WhatsApp: +91 78920 28951 🌐 www.doctorvisitbangalore.com
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a qualified thoracic oncologist or pulmonologist for diagnosis and treatment of lung cancer.
Arman Ali is the founder of Doctor Visit Bangalore, a trusted healthcare navigation platform helping patients find verified doctors, hospitals, and specialists across Bangalore and all over in India. With hands-on experience in healthcare research and patient assistance, Arman has personally helped hundreds of domestic and international patients connect with leading hospitals including Apollo, Manipal, Fortis, and Aster. His content is grounded in real hospital data, treatment cost research, and direct coordination with medical professionals across Bangalore. He specializes in medical tourism guidance, treatment cost transparency, and specialist discovery for complex conditions including cancer, cardiac surgery, and orthopedic care.